Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Sequoia Capital
MedTech
Virtue Diagnostics nets $100M for affordable in vitro testing
Virtue may be its own reward, but for Virtue Diagnostics, at least, a fresh infusion of venture capital is a close second.
Andrea Park
Jan 6, 2022 10:10am
Metis debuts with $86M to bankroll 2022 trial, gene therapy push
Dec 7, 2021 6:00am
China's Stemirna raises $188M to fund mRNA COVID-19 vaccine
Jun 4, 2021 8:25am
Digital health coach Noom nets $540M to tackle diabetes and more
May 25, 2021 11:25am
Benchling makes the A-team with $200M Series E
Apr 14, 2021 11:36am
Illumina, Sequoia Capital launch genomics incubator in China
Feb 1, 2021 10:22am
